Meetings/Forums…..
Reporting
Recent Decisions
Work in Development
Allocating Funding Based on Outcomes
Other
Childhood Immunisations – Changes to Reports on Transition to NIR
Details of the key messages resulting from the meeting will be communicated to you in the next bulletin.
A link to the meeting minutes and media statement released by the Governance Group after their teleconference held on 18 March 2011 is provided below.
http://www.dhbnz.org.nz/Site/SIG/pho/PHO/Governance-Group-Meetings-dates.aspx
1 March to 31 March 2011 data for the breast and cervical cancer, and influenza and childhood immunisation indicators is now available to PHOs on the DHBNZ Nexus website. The purpose of this data is to provide PHOs with a ‘snapshot’ of their performance against selected indicators for the month being reported.
There may be instances where data provided in the monthly reports does not coincide with data reported in the quarterly reports – this is because the validation process for collating the monthly reports is less stringent than the validation process used to collate the quarterly reports (meaning the Programme is able to report monthly data sets back to PHOs more quickly than the standard quarterly reporting process).
Inquiries may be directed to PHOPerformance@dhbnz.org.nz
The Phase Two – Final Reasonableness Reports for the period 1 October to 31 December 2010 process is now CLOSED - the information contained in this final Phase Two report will be used to formally report your performance for the period ending 31 December 2010.
The Phase One - Preliminary Reasonableness Reports for the period 1 January to 31 March 2011 are currently being processed – the Programme will notify you once these reports are available for verification.
Inquiries may be directed to PHOPerformance@dhbnz.org.nz
1 July to 31 December 2010 performance reports will be available to PHOs, DHBs and Ministry on the DHBNZ Nexus website on Friday 29 April 2011.
The Programme’s next set of PHO, DHB and Ministry of Health progress reports will be posted at the end of June 2011. These reports will report PHO progress against performance indicator targets to 31 March 2011.
Inquiries may be directed to PHOPerformance@dhbnz.org.nz
From the performance period commencing 1 January 2011, the ‘Smoking Status Ever Recorded’ indicator will be funded. The methodology that will be applied to set targets for this indicator is:
|
PHO baseline coverage rate (x) |
x < 40% |
40 ≤ x < 70% |
70 ≤ x < 90% |
|---|---|---|---|
|
Expected annual improvement |
20% point gain to maximum of 48% |
10% point gain to maximum of 77% |
5% point gain to maximum of 94.5% |
The following indicators will continue to be reported by the Programme as information only:
In addition, a single composite measure (of both the Brief Advice and Cessation Support indicators) will be introduced and reported by the Programme as information only from the performance period commencing 1 January 2011. The composite measure is:
This composite measure will have funding attached from 1 July 2011 and will only be available to PHOs that have coded 70% or more of their eligible population with a smoking status. Data collated from the introduction of this measure will be used by the Ministry of Health to report against the new primary care Smoking Health Target - ‘90 percent of enrolled patients who smoke and are seen in General Practice, will be provided with advice and help to quit by July 2012’. This Health Target is effective 1 July 2011 and will supersede the Ministry of Health’s 2010/11 National Goal.
Please note that the Programme Goal for the 2010/11 composite measure is ‘65% of enrolled patients who are current smokers, have been given brief advice and/or given or referred to cessation support services in the last 12 months’. The Programme Goal has been set, based on the assumption that only 82% of patients enrolled in a PHO will visit their general practitioner within a 12 month period. Given the Ministry’s 2010/11 National Goal currently sits at 80%, this equates to 65% of the enrolled population.
The PPP will communicate the Programme Goal that will apply for the 2011/12 Primary Care Health Target Indicator to stakeholders in due course.
Inquiries may be directed to Natasha.Maraku@dhbnz.org.nz
The following table lists the funded indicator set and weightings that are effective from 1 January 2011.
|
Chronic Conditions Indicators |
Annual % | |
|---|---|---|
|
Cervical Cancer Screening Coverage |
Total Population | 3.0 |
| Cervical Cancer Screening Coverage |
High Needs |
6.0 |
|
Breast Cancer Screening Coverage (50-69 years) |
High Needs | 6.0 |
|
Ischaemic Cardiovascular Disease Detection |
Total Population |
3.0 |
|
Ischaemic Cardiovascular Disease Detection |
High Needs |
6.0 |
|
Cardiovascular Disease Risk Assessment |
Total Population |
8.0 |
|
Cardiovascular Disease Risk Assessment |
High Needs |
12.0 |
|
Diabetes Detection |
Total Population | 3.0 |
|
Diabetes Detection |
High Needs |
6.0 |
|
Diabetes Follow Up After Detection |
Total Population |
3.0 |
|
Diabetes Follow Up After Detection |
High Needs |
6.0 |
|
Smoking Status Recorded |
Other |
2.0 |
|
Smoking Status Recorded |
High Needs |
5.0 |
|
Prevention of Infectious Diseases Indicators |
||
|
65+ Flu Vaccine Coverage |
Total Population |
3.0 |
|
65+ Flu Vaccine Coverage |
High Needs |
6.0 |
|
Age appropriate vaccinations for 2 year olds |
Total Population |
3.0 |
|
Age appropriate vaccinations for 2 year olds |
High Needs | 6.0 |
|
Financial Indicators |
||
|
GP Referred Laboratory Expenditure* |
Total Population |
6.5 |
|
GP Referred Pharmaceutical Expenditure* |
Total Population |
6.5 |
|
Total Score |
100.0 |
*Please be aware that the Financial Indicators will move to a status of information only from the performance period commencing 1 July 2011. Weightings will be revised in due course.
The Programme is actioning various activities that will enable us to report information back to the sector in a timelier manner.
The first change visible to the sector will be for the January to March 2011 Progress Reports. Normally, the Progress Report for this period would not be available until late July. However, with the changes we are implementing, an interim Progress Report will be available around 20 May. This interim report will contain Performance information for the following indicators:
Performance Information for the remaining indicators will be available in an updated Progress Report in late July (the normal timeframe for release of the Progress Report). The Progress Report will also be given a fresh look, with improved navigation and capabilities to quickly display and highlight pertinent information.
The due date for the CPI and Service Utilisation reports will remain unchanged, so PHO’s will not need to submit their data any earlier than normal. The timeframes for the Reasonableness Report process also remain unchanged, but PHO’s will now be required to validate your cervical screening and breast screening data in the Preliminary Reasonableness Report rather than the Final Reasonableness Report.
Further information regarding additional activities to improve the timeliness of Programme data will be communicated in future bulletins.
Inquiries may be directed to Shane.Kerr@dhbnz.org.nz
The Programme has developed a proposed set of second phase of CVD and Diabetes indicators. These indicators are:
The indicators focus on the delivery of appropriate treatment and on-going management of patients coded with CVD and Diabetes.
To check the feasibility and design of the indicators, the Governance Group has directed the Programme to pilot the indicators - decisions as to whether the indictors will be implemented in their proposed form (and timeframes) will be made by the Governance Group once piloting has been completed.
Inquiries may be directed to Natasha.Maraku@dhbnz.org.nz
The Programme’s Governance Group has agreed to changes in the derivation of indicator benchmarks for the RSM laboratory and pharmaceutical expenditure indicators, to an NHI based model using actual data (to ensure consistency with budgets). The Group has also endorsed changing the cost basis for the pharmaceutical model from the cost of pharmaceuticals to reimbursement costs.
Both of these changes will be effective from 1 July 2011.
A sub committee of the Programme’s Advisory Group has also been set up to consider how to ensure the best use of medicines/tests in the absence of funding for the RSM indicators. Further updates will be provided in due course.
Inquiries may be directed to Stewart.Pye@dhbnz.org.nz
A possible redesign of the funding formula for the Programme is being considered by the Programme’s Advisory Group in order to:
A two step outcomes payment system is being proposed to the Governance Group whereby Step 1 will see each PHO receive a payment based on their contribution to achievement of the national performance (adjusted for the national goal) and Step 2 sees an additional process introduced to reward top performing PHOs.
Discussions amongst the Advisory Group are continuing and a paper outlining the proposed approach has been tabled for Governance Group consideration when they next meet in June.
Further updates will be provided in due course.
Those of you who have agreed to an early transfer of data source for the childhood immunisations from the Service Utilisation Report (SUR) to the National Immunisation Register (NIR) will have noticed a significant change to the size of the numerator and denominator values in your reasonableness reports (approximately one quarter of your previously reported values). This reflects the revised basis for identifying eligibility to be counted.
Under SUR, all children who were two years old on the last day of the reporting period were counted, so most children were counted in 4 separate quarterly reports. The NIR only counts a child as they turn two years old, so in line with the selection criteria used for the Health Target only children who turned two during the quarter are now reported in the reasonableness report. The same principle will apply to progress reports which will now only report children turning 2 in the quarter. The performance reports, performance scorecard and public reports will report all children who turned 2 in the 6 monthly reporting period. For all reports, the PHO of affiliation will be determined by the PHO enrolment register applicable at the beginning of each reported quarter.
Overall the reduced period of selection should not affect the indicator value as both numerator and denominator values will be affected but the indicator will be more responsive to changes in performance as only the most recent period will contribute to the performance indicator.
Programme reports may report slightly lower performance than the NIR Milestone age reports simply because the Programme divides the number of fully immunised children by the number of enrolled children turning two years and not just those recorded on the NIR (such as may occur with children born overseas).
Childhood immunisation data are now included in the monthly reports. Please note that a practice will only be reported in these reports once at least one enrolled child has turned 2 since the beginning of the year. Thus in the first few months of the year practices with few young children will be absent from the monthly report. Once a child has been reported the practice will continue to be reported for the remainder of the year.
Inquiries may be directed to Stewart.Pye@dhbnz.org.nz
| Region | DHB | Contact |
|---|---|---|
| Northern Region |
|
Serena Curtis-Lemuelu (04) 803 5818 |
| Midland Region |
|
Stewart Pye (04) 803 5803 |
| Central Region |
|
Natasha Maraku (04) 803 5808 |
| Southern Region |
|
Shane Kerr (04) 803 5809 |
* For this purpose only
Inquiries that you would normally direct through the PHO Performance Programme mailbox can now be sent directly to your point of contact. The PHO Performance Programme mailbox will continue to be monitored by Merita Tuala and inquiries directed accordingly. This mailbox will continue to be used to communicate general business messages intended for all Programme contacts.
We expect these changes will enable us to respond to your inquiries more efficiently and effectively.